1. Gilead says remdesivir cut risk of COVID patient death in clinical trial — BioNTech-Pfizer COVID vaccine expected to be ready for approval by year end — LEO Pharma eyeing 2021 launch for Dupixent rival — See more on our front page news Stay updated with the latest pharma-related coronavirus news on our new page
    Dismiss Notice
  2. Please take our quick survey on how COVID-19 is impacting your job It will only take a minute or two to respond. The survey is confidential, and does not require registration. Thank you in advance for your participation. We will provide regular updates on results as responses accumulate.
    Dismiss Notice

Teva Neuroscience

Anonymous board for Teva Neuroscience


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    101
    Views:
    20,253
  2. anonymous
    Replies:
    0
    Views:
    183
  3. Anonymous
    Replies:
    0
    Views:
    364
  4. anonymous
    Replies:
    14
    Views:
    1,293
  5. anonymous
    Replies:
    9
    Views:
    1,318
  6. anonymous
    Replies:
    8
    Views:
    1,583
  7. anonymous
    Replies:
    13
    Views:
    2,217
  8. anonymous
    Replies:
    8
    Views:
    1,074
  9. anonymous
    Replies:
    45
    Views:
    5,268
  10. anonymous
    Replies:
    0
    Views:
    519
  11. anonymous
    Replies:
    73
    Views:
    11,555
  12. anonymous
    Replies:
    15
    Views:
    1,936
  13. anonymous
    Replies:
    15
    Views:
    1,922
  14. NBIX
    Replies:
    9
    Views:
    3,195
  15. anonymous
    Replies:
    1
    Views:
    983
  16. anonymous
    Replies:
    34
    Views:
    7,956
  17. anonymous
    Replies:
    3
    Views:
    1,369
  18. Psych expansion
    Replies:
    1
    Views:
    577
  19. anonymous
    Replies:
    0
    Views:
    1,070
  20. anonymous
    Replies:
    1
    Views:
    1,271

Thread Display Options

Loading...